Happiness Biotech Group Ltd. (HAPP)
| Market Cap | 41.44M |
| Revenue (ttm) | 65.06M |
| Net Income (ttm) | 12.69M |
| Shares Out | 25.90M |
| EPS (ttm) | 0.80 |
| PE Ratio | 2.07 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 14 |
| Last Price | $1.65 |
| Previous Close | $1.60 |
| Change ($) | 0.05 |
| Change (%) | 3.12% |
| Day's Open | 1.62 |
| Day's Range | 1.62 - 1.66 |
| Day's Volume | 85,183 |
| 52-Week Range | 1.60 - 3.23 |
Happiness Biotech Group (HAPP) is seeing shares of HAPP stock take off on Monday following positive news from one of its subsidiaries. The post HAPP Stock Alert: 4 Things to Know About Happiness Biotech...
As of Dec. 10, the GuruFocus All-in-One Screener, a Premium feature, found that the following health care companies have low price-earnings ratios and are owned by gurus. While some of them are great va...
There are some investors who purchase stocks that are trading below their liquidation value because they believe they can make gains out of their investments after the market has reassessed the share pr...
About HAPP
Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powder, cordyceps mycelia, ejiao solution, American ginseng, and other products. It also offers a range of ganoderma lucidum products, such as essence oil, cleansing milk, shampoo, shower gel, and nourishing cream products under the Cai Zhi Ning brand, as well as edible fungi. In addition, the compa... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Oct 25, 2019 |
| Stock Exchange NASDAQ | Ticker Symbol HAPP |
Financial Performance
In 2019, HAPP's revenue was $65.06 million, an increase of 1.76% compared to the previous year's $63.94 million. Earnings were $12.69 million, a decrease of -32.23%.